site stats

Btai stock price target

WebApr 11, 2024 · BTAI has been the topic of several research reports. The Goldman Sachs Group raised their price target on shares of BioXcel Therapeutics from $16.00 to $26.00 and gave the company a “neutral ... WebBTAI has a higher average analyst price target than 2939.86% of stocks in the small market cap category. In the context of stocks in the small market cap category, BIOXCEL …

BTAI Price Target, Analyst Ratings and Predictions

WebBioXcel Therapeutics (NASDAQ:BTAI) had a huge reversal on big volume Thursday, popping 1.95, or 81%, to 4.36, on 2.7 million shares and closed at the upper end of the... BioXcel Therapeutics... WebApr 12, 2024 · The latest price target for BioXcel Therapeutics ( NASDAQ: BTAI) was reported by Jefferies on March 10, 2024. The analyst firm set a price target for $22.00 … trower and trower https://4ceofnature.com

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Receives Consensus ...

WebApr 6, 2024 · The price target raised to $80 per share is four times as large as the last closing price. BXCL501, the treatment identified as Igalmi after its FDA approval, is … WebThe analyst firm set a price target for 66.00 expecting BTAI to rise to within 12 months (a possible 282.17% upside). 16 analyst firms have reported ratings in the last year. WebApr 10, 2024 · Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $50.00. BioXCel Therapeutics (NASDAQ:BTAI) A Hot Buy That Confuses Analysts trower and hamlins london

BioXcel Therapeutics, Inc. (BTAI) - Stock Analysis

Category:SMMT Stock Forecast, Price & News (Summit Therapeutics)

Tags:Btai stock price target

Btai stock price target

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Receives Consensus ...

WebApr 10, 2024 · A number of equities research analysts have recently weighed in on BTAI shares. HC Wainwright lowered their price target on BioXcel Therapeutics from $79.00 to $66.00 and set a “buy” rating... WebApr 5, 2024 · 7 analysts have issued 12 month price targets for BioXcel Therapeutics' stock. Their BTAI share price forecasts range from $22.00 to $76.00. On average, they expect …

Btai stock price target

Did you know?

WebApr 9, 2024 · BTAI Price Target 2024 BioXcel Therapeutics Analyst Ratings NASDAQ:BTAI BioXcel Therapeutics - BTAI Price Target & Analyst Ratings $18.66 +0.06 (+0.32%) (As of 03/31/2024 12:00 AM ET) Compare Today's Range $18.34 $19.27 50 … WebApr 5, 2024 · BioXcel Therapeutics Inc (BTAI) stock is higher by 1.12% while the S&P 500 has fallen -0.53% as of 10:38 AM on Tuesday, Apr 5. BTAI has gained $0.23 from the …

WebBioXcel Therapeutics, Inc. (BTAI) Stock Price, News, Quote & History - Yahoo Finance My Portfolio Crypto Dow 30 Russell 2000 Crude Oil (-0.30%) BioXcel Therapeutics, Inc. … WebBTAI: Get the latest BioXcel Therapeutics stock price and detailed information including BTAI news, historical charts and realtime prices.

WebApr 10, 2024 · BioXcel Therapeutics Stock Performance Shares of NASDAQ:BTAI opened at $17.28 on Monday. The business’s 50 day moving average price is $25.69 and its 200-day moving average price is $20.40....

WebJan 13, 2024 · BTAI stock touched a high of $64.60 in July. The stock has been in consolidation range. A breakout on the upside seems imminent. To back my view, the median estimate of seven analysts...

WebApr 11, 2024 · Summit Therapeutics - SMMT Stock Forecast, Price & News $1.53 -0.04 (-2.55%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $1.51 $1.61 50-Day Range $1.38 $3.88 52-Week Range $0.66 $5.78 Volume 1.17 million shs Average Volume 2.79 million shs Market Capitalization $1.07 billion P/E Ratio N/A Dividend Yield N/A Price … trower and trower incWebFind real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. trower bradfordWebPrice To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for BioXcel Therapeutics (BTAI) trower ham cl eWeb1 day ago · Currently, the analyst consensus on Bioxcel Therapeutics is a Moderate Buy with an average price target of $49.33. See Insiders’ Hot Stocks on TipRanks >> The … trower falvo architectsWebStock Price Forecast The 10 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 49.00, with a high estimate of 75.00 and a low … trower bridge of sighs lyricsWebWhat is BTAI's Price Target? According to 6 Wall Street analyst s that have issued a 1 year BTAI price target, the average BTAI price target is $42.17 , with the highest BTAI … trower hamlins procurementWebApr 12, 2024 · Discover historical prices for BTAI stock on Yahoo Finance. View daily, weekly or monthly format back to when BioXcel Therapeutics, Inc. stock was issued. trower gray and associates